The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Year By Year Historical Returns Index Funds provides year-by-year results to assess consistency and identify standout years across funds.
25,344 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
AMD investors face a bumpy road as market reality clashes with AI optimism. This guide explains what unfortunate news...
NVIDIA signals a potential shift in its OpenAI investment with new discussions about winding down the stake. The news...
A bipartisan proposal aims to cap Social Security benefits for the wealthiest couples to address long-term solvency c...
Anthropic has filed a confidential S-1, triggering a summer wave of AI IPO chatter. Private-market dynamics, competit...
Crypto markets may be thawing after a years-long winter. This deep-dive explains the signals behind the claim and off...
Fresh analyst notes Thursday spark upgrades across Alphabet, Meta, Palo Alto Networks and more, signaling growing opt...
Tech-led selling pushed the Nasdaq Composite lower as investors weigh higher yields and fresh data. The broader marke...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Markets paused their march higher at midday as tech leadership shines and geopolitical headwinds test appetite. Marve...
Ethereum’s latest rally fires up optimism, yet market watchers warn a 15% pullback could unfold in the near term as o...
Small-cap stocks are delivering the sharpest outperformance versus the S&P 500 in years, with a roughly 20% YTD g...